Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease
Author:
Publisher
Wiley
Subject
Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.2009.00170.x/fullpdf
Reference137 articles.
1. Non-redundant function of phosphodiesterase 4D and 4B in neutrophil recruitment to the site of inflammation;Ariga;J Immunol,2004
2. The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation;Banner;Br J Pharmacol,1996
3. Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers;Barber;Am J Physiol Lung Cell Mol Physiol,2004
4. New therapies for chronic obstructive pulmonary disease;Barnes;Thorax,1998
5. New concepts in chronic obstructive pulmonary disease;Barnes;Annu Rev Med,2003
Cited by 93 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The perspective of cAMP/cGMP signaling and cyclic nucleotide phosphodiesterases in aortic aneurysm and dissection;Vascular Pharmacology;2024-03
2. Perspectives on Ensifentrine and Its Therapeutic Potential in the Treatment of COPD: Evidence to Date;International Journal of Chronic Obstructive Pulmonary Disease;2024-01
3. Discovery of 2-(Methylcarbonylamino) thiazole as PDE4 inhibitors via virtual screening and biological evaluation;Journal of Molecular Graphics and Modelling;2023-11
4. Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials);American Journal of Respiratory and Critical Care Medicine;2023-08-15
5. Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD;International Journal of Chronic Obstructive Pulmonary Disease;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3